About
Large drug maker
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalRussia
Clinical Trials (23)
View allTotal Trials
23
As Lead Sponsor
23
As Collaborator
0
Total Enrollment
2,379
By Phase
PHASE1: 6PHASE3: 7NA: 10
By Status
COMPLETED: 20UNKNOWN: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline23 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06497049Lead Sponsor
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
PHASE1Completed
120 participants
Started: Jun 30, 2023 · Completed: May 5, 2024
NCT07070752Lead Sponsor
Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients
PHASE3Completed
224 participants
Started: Apr 14, 2023 · Completed: Nov 28, 2023
NCT06497036Lead Sponsor
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia
PHASE3Active, not recruiting
160 participants
Started: Apr 4, 2023 · Completed: Mar 31, 2028
NCT05652595Lead Sponsor
Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141
PHASE1Unknown
56 participants
Started: Jun 3, 2022 · Completed: Sep 30, 2024
NCT05648799Lead Sponsor
Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia)
NACompleted
246 participants
Started: Mar 17, 2022 · Completed: Jul 20, 2022
Locations (1)
Headquarters
Moscow, Russia
Map
Loading map...